Association of myasthenia gravis and Behçet's disease: A case report
| dc.contributor.author | Kisabay A. | |
| dc.contributor.author | Sari U.S. | |
| dc.contributor.author | Boyaci R. | |
| dc.contributor.author | Batum M. | |
| dc.contributor.author | Yilmaz H. | |
| dc.contributor.author | Selcuki D. | |
| dc.date.accessioned | 2025-04-10T11:09:33Z | |
| dc.date.available | 2025-04-10T11:09:33Z | |
| dc.date.issued | 2016 | |
| dc.description.abstract | Myasthenia gravis is a disease of neuromuscular junction due to auto-immune destruction of the acetylcholine receptors. Behçet's disease, on the other hand, is a multisystemic vascular-inflammatory disease. Both conditions are not common in the general population although their association has not been reported in the literature. We wanted to present our patient who developed clinical course of myasthenia gravis following discontinuation of medications due to complications of corticosteroid for Behçet's disease. It was observed that clinical findings of myasthenia gravis recovered following restarting steroid treatment and he did not experience attacks of both conditions. Although Myasthenia gravis and Behçet's disease are distinct entities clinically as well as in terms of pathogenesis, they share common physiopathological features and their treatment is based on their common features. © 2016 Polish Neurological Society | |
| dc.identifier.DOI-ID | 10.1016/j.pjnns.2016.03.007 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.14701/48812 | |
| dc.publisher | Urban and Partner | |
| dc.title | Association of myasthenia gravis and Behçet's disease: A case report | |
| dc.type | Article |